Using Bacteria Or Actinomycetales Patents (Class 435/822)

Cross-Reference Art Collections

Acetobacter (Class 435/823)
  • Patent number: 5910440
    Abstract: A process to remove organic sulfur from organic compounds and organic carbonaceous fuel substrates containing sulfur compounds having sulfur-carbon bonds is disclosed. The steps of the process include oxidizing the sulfur species to the sulfone and/or sulfoxide form, and reacting the sulfone and/or sulfoxide form in an aqueous media of the reacting step including a hydride transfer reducing agent. In a particular embodiment, the reducing agent is sodium formate, the oxidizing agent is a microorganism as exemplified by Rhodococcus species ATCC 55309 or Rhodococcus species ATCC 55310 or combinations thereof.
    Type: Grant
    Filed: April 12, 1996
    Date of Patent: June 8, 1999
    Assignee: Exxon Research and Engineering Company
    Inventors: Matthew J. Grossman, Michael Siskin, David T. Ferrughelli, M. Kathryn Lee, James D. Senius
  • Patent number: 5902581
    Abstract: A purified xylanase produced by Acidothermus cellulolyticus is disclosed having a pH optimum of between about 3.6-4.2 and a molecular weight of between about 50-55 kD as determined by gel filtration. The disclosed xylanase is useful in the bleaching of pulp for the production of paper and in treating feed compositions.
    Type: Grant
    Filed: December 4, 1995
    Date of Patent: May 11, 1999
    Assignee: Genencor International, Inc.
    Inventors: Kathleen A. Clarkson, Andrew J. Morgan, Zhi C. Wang
  • Patent number: 5902744
    Abstract: The present invention provides a process of decontaminating, by composting under specific conditions, soil and/or sediments containing certain toxic cyclical organic compound contaminants by converting these contaminants into harmless materials. The compounds include chlordane, dieldrin, toxaphene, aldrin, endrin, and heptachlorepoxide. The process includes the step of affecting a solid compost mixture during composting with a redox potential below negative 200 mV (millivolts). Further, the process includes several steps which are repeated until an amount of contaminant is degraded to less than 140 ppm (part per million) per ton of soil.
    Type: Grant
    Filed: November 1, 1996
    Date of Patent: May 11, 1999
    Assignee: Stauffer Management Company
    Inventors: Neil Cameron Croall Gray, Guy Peter Moser, Lovi Eva Moser
  • Patent number: 5902743
    Abstract: Disclosed herein is a Bifidobacterium strain isolate. It can be used as an additive to infant food and beverage products, as well as to provide a healthful bacteria to human adults and non-human mammals. The bacterium acts as a probiotic. For example, the bacterium assists newborns in producing protective acetic acid and lactic acid, as well as antimicrobials and vitamins. The bacterium can also be used to reseed bacteria levels caused by diarrhea, chemotherapy, advancing age, antibiotics, or other causes.
    Type: Grant
    Filed: March 20, 1998
    Date of Patent: May 11, 1999
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: John B. Luchansky, Shu-Jean Tsai
  • Patent number: 5895648
    Abstract: The invention relates to a composition for feed use containing a mixture of lyophilized live bacteria comprising at least two species of bacteria selected from Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium longum and Bifidobacterium bifidum and at least two species of bacteria selected from Lactobacillus acidophilus, Streptococcus thermophilus, Lactobacillus bulgaricus, Lactobacillus casei, Lactobacillus plantarum and Streptococcus faecium and one or more oligosaccharides.
    Type: Grant
    Filed: September 3, 1997
    Date of Patent: April 20, 1999
    Assignee: Sitia-Yomo S.p.A.
    Inventors: Renata Cavaliere Vesely, Giovanni Giani, Gianluigi Maiocchi, Marco Emilio Vesely, Leonardo Vesely
  • Patent number: 5891709
    Abstract: A solid or semi-solid culture medium, designated Campy-Cefex, for the isolation of Campylobacter species. The culture medium includes:(a) a nutrient medium with an energy source effective to support growth of Campylobacter;(b) agar;(c) blood;(d) a first selective agent selected from cycloheximide, its salts, or mixtures thereof; and(e) a second selective agent selected from cefoperazone, its salts, or mires thereof.In use, the sample to be analyzed is inoculated onto the Campy-Cefex culture medium, and subsequently incubated for a sufficient time and under conditions effective to promote growth of Campylobacter. Following incubation, the culture medium may then be examined for the presence of any colonies of Campylobacter.
    Type: Grant
    Filed: July 13, 1992
    Date of Patent: April 6, 1999
    Assignee: The United States of America as represented by the Secretary of the Agriculture
    Inventors: Norman J. Stern, Boleslaw J. Wojton, Kris Kwiatek
  • Patent number: 5888786
    Abstract: An expression vector containing both a DNA encoding an L-sorbose dehydrogenase and a DNA encoding an L-sorbosone dehydrogenase; a transformant having an ability to produce 2-keto-L-gulonic acid (hereinafter 2KLGA) at high yields from D-sorbitol, which is prepared by transforming, with said expression vector, a microorganism capable of producing L-sorbose at high yields from D-sorbitol, which has no or low 2KLGA-decomposing activity or a host microorganism having, in addition to the above-mentioned properties, no or low L-idonic acid-producing activity; and a process for producing 2KLGA, which comprises culturing said transformant in a medium containing D-sorbitol. According to the present invention, 2KLGA useful for the production of L-ascorbic acid can be produced with ease and in larger amounts by a single operation of culture.
    Type: Grant
    Filed: October 3, 1997
    Date of Patent: March 30, 1999
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Mineo Niwa, Yoshimasa Saito, Yoshinori Ishii, Masaru Yoshida, Hiromi Hayashi
  • Patent number: 5882917
    Abstract: A survival method for a foreign microorganism, which comprises the steps of disturbing the equilibrium state of an ecosystem in which plural kinds of microorganisms coexist, to temporarily bring the ecosystem into a non-equilibrium state, and then introducing a foreign microorganism into the ecosystem. There are three states of equilibrium involved of which comprise a first state wherein the ecosystem is in equilibrium, a second state wherein the ecosystem is converted to a state which is not in equilibrium, and a third state wherein the ecosystem is converted to a new state of equilibrium to provide for an ecological niche for survival of an introduced foreign microorganism in the ecosystem. The foreign microorganism is also used in a method for remedying an environment contaminated with a pollutant.
    Type: Grant
    Filed: September 10, 1997
    Date of Patent: March 16, 1999
    Assignee: Canon Kabushiki Kaisha
    Inventors: Masanori Sakuranaga, Kazumi Tanaka, Tsunehiro Kanno
  • Patent number: 5882900
    Abstract: A method for increasing both total antibiotic yield the selective production of factor A of the GE 2270 antibiotics consisting in the addition of vitamin B.sub.12 or its analogs having vitamin B.sub.12 --like activity to the fermentation media of Planobispora rosea ATCC 53773 or any antibiotic GE 2270 producing mutant or variant thereof.
    Type: Grant
    Filed: September 30, 1997
    Date of Patent: March 16, 1999
    Assignee: Gruppo Lepetit S.p.A.
    Inventors: Angelo Michele Rizzo, Luciano Gastaldo
  • Patent number: 5874262
    Abstract: A microbiological process for the preparation of N,N'-ethylenediaminedisuccinic acid of formula (1), by (a) precultivation of a strain of the genus Amycolatopsis orientalis on a specified nutrient medium (1st preculture), (b) inoculation of a nutrient solution of the same composition as the base of the production fermenter by the 1st preculture (2nd preculture), (c) inoculation of the base nutrient solution in the production fermenter with the 2nd preculture and incubation in accordance with a specified timetable, (d) feeding of the production fermenter in the fed-batch process with a feeding solution under aerobic conditions at a pH of from 2 to 8 and at a temperature of from 15.degree. to 40.degree. C., wherein the base nutrient and feeding solutions are free of zinc-containing compounds, is described. The compound prepared by the process according to the invention is suitable as complexing agent with good biodegradability in detergents.
    Type: Grant
    Filed: November 17, 1997
    Date of Patent: February 23, 1999
    Assignee: Ciba Specialty Chemicals Corporation
    Inventors: Hans Zahner, Ingeborg Cebulla, Michael Harder
  • Patent number: 5871948
    Abstract: The invention relates to an ammonia elimination reagent for use in an enzymatic assay of a biological substance which produces ammonia as the reaction product. The reagent is an alkaline solution of pH 9 to 11 and contains Sulfolobus-derived thermostable isocitrate dehydrogenase, 2-oxoglutaric acid, a reducing coenzyme, isocitric acid, glutamate dehydrogenase, and a divalent metal salt. The reagent can be stored in solution and has excellent stability under conditions of alkaline pHs.
    Type: Grant
    Filed: June 20, 1996
    Date of Patent: February 16, 1999
    Assignee: Oriental Yeast Co., Ltd.
    Inventors: Hirokazu Matsukawa, Tuyosi Fujita, Tairo Oshima
  • Patent number: 5869066
    Abstract: This invention relates generally to in vitro methods for inducing or enhancing expression of enteric bacterial antigens and/or virulence factors thereby producing antigenically enhanced enteric bacteria, to methods for using antigenically enhanced enteric bacteria and to vaccines comprising antigenically enhanced enteric bacteria. Further, a vaccine comprising a Campylobacter bacterium having en enhanced antigenic property is disclosed. The culture medium conditions comprise 0.05% to 3% bile or 0.025% to 0.6% of one or more bile acids or salts. In addition a divalent cation chelator can also be included in the culture medium. The bacteria culture is in a growth phase at early log phase and between early log phase and stationary phase. The enhanced antigenic property is a higher level of an immunogenic antigen when compared to the antigenic property of the same bacteria grown on brain heart infusion broth.
    Type: Grant
    Filed: May 30, 1997
    Date of Patent: February 9, 1999
    Assignee: Antex Biologics Inc.
    Inventors: John Lee Pace, Richard Ives Walker, Steven Michael Frey
  • Patent number: 5866379
    Abstract: Enzymes derived from the isolated and substantially purified microorganisms of the present invention, designated herein as strains 52 and 56wt, are capable of hydrating nitriles such as 2-hydroxy-4-(methylthio)-butanenitrile (HMB-nitrile) to their corresponding amides, and further, of hydrolyzing amides such as 2-hydroxy-4-(methylthio)-butaneamide (HMB-amide) to their corresponding carboxylic acids. Advantageously, the nitrile hydratase of these strains is not substantially inhibited by the .alpha.-hydroxybutyramide product being formed; rather, this enzyme maintains the ability to hydrate an .alpha.-hydroxybutyronitrile to its corresponding amide even at high amide concentrations, including at saturating amide conditions. As such, enzymes derived from strains 52 and 56wt are particularly suited for commercial use in preparing agrichemical intermediates such as HMB-amide.
    Type: Grant
    Filed: January 28, 1997
    Date of Patent: February 2, 1999
    Assignee: Novus International
    Inventors: Richard P. Burlingame, James R. Millis, Fernando Sanchez-Riera, Thomas F. Blackburn, Alan D. Grund
  • Patent number: 5866375
    Abstract: Method for the culture of microorganisms of the genera Helicobacter, Campylobacter and Arcobacter, wherein culture media are employed, which comprise, in place of blood or its derivative, cyclodextrins.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: February 2, 1999
    Assignee: Chiron S.p.A.
    Inventors: Natale Figura, Massimo Bugnoli, Roberto Olivieri, Rino Rappuoli
  • Patent number: 5861289
    Abstract: Described herein are a novel heat-resistant .beta.-galactosyltransferase, a production process of the enzyme and a utilization method of the enzyme. The enzyme is produced preferably by produced by a microorganism belonging to the family of Actinomycetaceae, which may be selected from fungi belonging to the genus Saccharopolyspora, the genus Thermomonospora or the genus Thermoactinomvces.
    Type: Grant
    Filed: May 3, 1993
    Date of Patent: January 19, 1999
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Toru Nakayama, Yukiko Kodama, Norihide Amano, Masahiro Nakao, Yuji Shibano, Teruo Amachi
  • Patent number: 5861292
    Abstract: A novel L-sorbose dehydrogenase (SDH) and a novel L-sorbosone dehydrogenase (SNDH) both derived from Gluconobacter oxydans T-100, a DNA which encodes the SDH and/or SNDH, an expression vector which contains the DNA, a host cell transformed by the expression vector and a process for producing the SDH and/or SNDH, which comprises culturing the host cell in a medium and recovering the SDH and/or SNDH from the resulting culture. The SDH and SNDH of the present invention are useful enzymes having preferable properties for the production of 2-keto-L-gulonic acid, as well as L-ascorbic acid. According to the production method of the present invention, the SDH and SNDH having such preferable properties can be produced in large amounts by genetic engineering.
    Type: Grant
    Filed: October 2, 1997
    Date of Patent: January 19, 1999
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Mineo Niwa, Yoshimasa Saito, Yoshinori Ishii, Masaru Yoshida, Hiromi Suzuki
  • Patent number: 5858737
    Abstract: A process is disclosed that bioconverts indene to (1S)-amino-(2R)-indanol substantially free of any of its stereoisomers, by the action of a strain of P. putida or Rhodococcus sp., followed by various chemical step(s), e.g., chiral specific crystallization, treatment with strong acid in the presence of acetonitrile.
    Type: Grant
    Filed: August 14, 1996
    Date of Patent: January 12, 1999
    Assignee: Merck & Co., Inc.
    Inventors: Barry C. Buckland, Neal C. Connors, Michel M. Chartrain, Francis P. Gailliot, Randolph L. Greasham, Barbara Jackey, Brian Heimbuch, Chanyong Lee, Roger C. Olewinski, Jr., F. Edward Roberts, Paul J. Reider, Thomas R. Verhoeven, Chris H. Senanayake
  • Patent number: 5858352
    Abstract: Methods using in vitro processes are disclosed for inducing or enhancing expression of enteric bacterial antigens or virulence factors. The methods, therefore, produce antigenically enhanced bacteria for use in vaccines. Also disclosed are methods for using the antigenically enhanced bacteria as well as the vaccines containing the enteric bacteria. Specifically, a whole enteric bacteria or components thereof, are provided by Shigella species. In addition to this microorganism there are other enteric bacteria, such as Campylobacter species and Helicobacter pylori, which are useful for inducing or enhancing expression of enteric bacterial antigens and/or virulence factors.
    Type: Grant
    Filed: May 30, 1997
    Date of Patent: January 12, 1999
    Assignee: Antex Biologics Inc.
    Inventors: John Lee Pace, Richard Ives Walker, Steven Michael Frey
  • Patent number: 5858700
    Abstract: A process for isolating and purifying lycopene crystals from a biological lycopene source is disclosed. A lycopene-containing oleoresin is saponified in a composition of propylene glycol and aqueous alkali to form lycopene crystals. Crystallization is achieved without the use of added organic solvents. The crystals are isolated and purified. The substantially pure lycopene crystals so obtained are suitable for human consumption and can be used as a nutritional supplement and as an additive in food.
    Type: Grant
    Filed: April 3, 1997
    Date of Patent: January 12, 1999
    Assignee: Kemin Foods, LC
    Inventors: Rodney L. Ausich, David J. Sanders
  • Patent number: 5856146
    Abstract: Disclosed is a recombinant thermostable enzyme which has a molecular weight of about 54,000-64,000 daltons and a pI of about 5.6-6.6, and releases trehalose from non-reducing saccharides having a trehalose structure as an end unit and a degree of glucose polymerization of at least 3. The enzyme has a satisfactorily-high thermostability, i.e. it is not substantially inactivated even when incubated in an aqueous solution (pH 7.0) at 85.degree. C. for 60 min, and this facilitates the production of trehalose on an industial scale and in a satisfactorily-high yield.
    Type: Grant
    Filed: July 21, 1995
    Date of Patent: January 5, 1999
    Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
    Inventors: Hitoshi Mitsuzumi, Michio Kubota, Toshiyuki Sugimoto
  • Patent number: 5851810
    Abstract: The present invention provides a purified and isolated nucleic acid encoding Rhodococcus L-phenylalanine dehydrogenase. The present invention also provides a vector comprising nucleic acid encoding Rhodoccus L-phenylalanine dehydrogenase, a host cell transformed with the vector, and a method for producing recombinant L-phenylalanine dehydrogenase.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: December 22, 1998
    Assignee: Albert Einstein College of Medicine of Yeshiva University, a Division of Yeshiva University
    Inventor: John S. Blanchard
  • Patent number: 5849284
    Abstract: The invention disclosed is related to a composition for the control of molluscs wherein an effective amount of infective dauer larvae of Phasmarhabditis nematodes which have been cultured with a nematode growth promoting and pathogenicity-inducing bacterium, as well as a carrier or encapsulation agent are provided as the ingredients for the composition. Further, the composition can be used in the form of a water-dispersable powder comprising as the carrier a calcium montmorillonite clay. The nematode concentration in the water-dispersable powder is 0.1.times.10.sup.6 to 2.0.times.10.sup.6 per gram of total composition (wet weight), and preferably from 0.3.times.10.sup.6 to 0.8.times.10.sup.6 per gram of the total composition (wet weight). Further, the nematodes are selected from amongst the species P. neopapillosa or P. hermaphrodita. The growth promoting bacterium is a Moraxella osloensis strain or Pseudomonas fluorescens strain.
    Type: Grant
    Filed: March 29, 1996
    Date of Patent: December 15, 1998
    Assignee: Agricultural Genetics Company Ltd.
    Inventors: Michael John Wilson, David McKellar Glen, Jeremy David Pearce
  • Patent number: 5846789
    Abstract: A process for preparing a nontoxic lipopolysaccharide, which comprises (i) cultivating in a culture medium bacteria of the genus Acidophilium having accession No. MTCC 1979, (ii) separating the culture bacteria, and repeatedly washing the separated bacteria, (iii) extracting the washed bacteria with a lipophilic solvent, (iv) cooling the extract and repeatedly centrifuging the cooled material, (v) dialyzing the supernatant resulting from said centrifuging, (vi) lyophilizing the dialyzed material, (vii) precipitating the lipopolysaccharide by treating the lyophilized material with a polar solvent, and (viii) drying the precipitated polyliposaccharide.
    Type: Grant
    Filed: December 10, 1996
    Date of Patent: December 8, 1998
    Assignee: Council of Scientific and Industrial Research
    Inventors: Ranjan Bhadra, Abhijit Nayak, Pataki Charan Bandyopadhyay, Sumanta Basu
  • Patent number: 5846812
    Abstract: The present invention provides a bacterial microorganism having the ability to degrade or detoxify zearalenone or derivatives or analogs of zearalenone. The present invention also provides a method for the isolation and utilization of a zearalenone-degradation gene encoding a gene product having the ability to degrade or detoxify zearalenone or derivatives or analogs of zearalenone. In another embodiment, the present invention provides for the generation of transformants into which the zearalenone-degradation gene has been introduced, thereby providing the ability to degrade or detoxify zearalenone or derivatives or analogs of zearalenone to said transformants. The present invention further provides a method for detoxification of plants pre- or post-harvest using microbes having the ability to degrade or detoxify zearalenone or derivatives or analogs of zearalenone. The invention also provides a method for detoxification of plants pre- or post-harvest using the zearalenone-degradation gene.
    Type: Grant
    Filed: November 22, 1996
    Date of Patent: December 8, 1998
    Assignee: Pioneer Hi-Bred International, Inc.
    Inventors: Jon Duvick, Tracy A. Rood
  • Patent number: 5843760
    Abstract: This invention relates to single microorganisms which normally do not ferment pentose sugars which are genetically altered to ferment the pentose sugars, xylose and arabinose, to produce ethanol, and a fermentation process utilizing the same. Examples include Zymomonas mobilis which has been transformed with a combination of E. coli genes for xylose isomerase, xylulokinase, L-arabinose isomerase, L-ribulokinase, L-ribulose 5-phosphate 4-epimerase, transaldolase and transketolase. Expression of added genes are under the control of Z. mobilis promoters. These newly created microorganisms are useful for fermenting glucose, xylose and arabinose, produced by hydrolysis of hemicellulose and cellulose or starch, to produce ethanol.
    Type: Grant
    Filed: May 6, 1997
    Date of Patent: December 1, 1998
    Assignee: Midwest Research Institute
    Inventors: Min Zhang, Yat-Chen Chou, Stephen K. Picataggio, Mark Finkelstein
  • Patent number: 5843669
    Abstract: The present invention relates to means for cleaving a nucleic acid cleavage structure in a site-specific manner. Structure-specific nucleases, including 5' nucleases, thermostable FEN-1 endonucleases and 3' exonucleases, are used to detect and identify target nucleic acids. Methods are provided which allow for the detection specific nucleic acid sequences; these methods permit the detection and identification of mutant and wild-type forms of genes (e.g., human genes) as well as permit the detection and identification of bacterial and viral pathogens in a sample.
    Type: Grant
    Filed: November 29, 1996
    Date of Patent: December 1, 1998
    Assignee: Third Wave Technologies, Inc.
    Inventors: Michael W. Kaiser, Victor I. Lyamichev, Natasha Lyamichev
  • Patent number: 5840571
    Abstract: A Process using anaerobic, aerobic, and cometabolizing bacteria to biodegrade halogenated organic compounds in an unsaturated zone lyng between the ground surface and the underlying water table is disclosed. The process includes contacting in situ an electron donor compound with dehalogenating bacteria indigenous in or added thereto in the unsaturated soil zone which is between the ground surface and underlying water table. Further the halogenated component compounds also react with the bacteria and electron donor; thus, stimulating biodegradation while cycling between aerobic and anaerobic as well as cometabolic environments during the process.
    Type: Grant
    Filed: December 12, 1995
    Date of Patent: November 24, 1998
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Ralph Emerson Beeman, Stephen Hoover Shoemaker
  • Patent number: 5840861
    Abstract: New A83543 components, including fermentation products A83543K, A835430, A83543P, A83543U, A83543V, A83543W and A83543Y and N-demethyl derivatives, and salts thereof, are useful for the control of insects and mites. The pseudoaglycones of the new A83543 components are useful for the preparation of A83543 components. Methods are provided for making the new A83543 components by culturing of Saccharopolyspora spinosa NRRL 18395, NRRL 18537, NRRL 18538, or NRRL 18539, or NRRL 18743 or NRRL 18719 or NRRL 18823 in suitable culture medium. Insecticidal and ectoparasiticidal compositions containing new A83543 components are also provided.
    Type: Grant
    Filed: February 8, 1995
    Date of Patent: November 24, 1998
    Assignee: DowElanco
    Inventors: Jon S. Mynderse, Mary C. Broughton, Walter M. Nakatsukasa, James A. Mabe, Jan R. Turner, Lawrence Creemer, Mary L. B. Huber, Herbert A. Kirst, James W. Martin
  • Patent number: 5834263
    Abstract: An expression vector containing both a DNA encoding an L-sorbose dehydrogenase and a DNA encoding an L-sorbosone dehydrogenase; a transformant having an ability to produce 2-keto-L-gulonic acid (hereinafter 2KLGA) at high yields from D-sorbitol, which is prepared by transforming, with said expression vector, a microorganism capable of producing L-sorbose at high yields from D-sorbitol, which has no or low 2KLGA-decomposing activity or a host microorganism having, in addition to the above-mentioned properties, no or low L-idonic acid-producing activity; and a process for producing 2KLGA, which comprises culturing said transformant in a medium containing D-sorbitol. According to the present invention, 2KLGA useful for the production of L-ascorbic acid can be produced with ease and in larger amounts by a single operation of culture.
    Type: Grant
    Filed: September 24, 1996
    Date of Patent: November 10, 1998
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Mineo Niwa, Yoshimasa Saito, Yoshinori Ishii, Masaru Yoshida, Hiromi Hayashi
  • Patent number: 5830702
    Abstract: Vaccines comprising an attenuated strain of Listeria spp. expressing a selected foreign antigen and methods of eliciting protective immunity by administering an effective amount of the vaccine are provided. The vaccines of the present invention are designed specifically to elicit strong cell-mediated immunity, and are particularly useful for protection in infections which can apparently persist and spread in the presence of neutralizing antibodies invoked by humoral immunity.
    Type: Grant
    Filed: December 30, 1994
    Date of Patent: November 3, 1998
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Daniel A. Portnoy, Yvonne Paterson
  • Patent number: 5831042
    Abstract: Chemically modified succinoglycan polysaccharides, e.g., acidic or enzymatic hydrolysates, have a reduced content of pyruvic acid and succinic acid structural units relative to the unmodified such succinoglycans, and are well suited, whether in fibrous, powdery or gel state, for use, e.g., as thickening stabilizing or suspending agents, in foodstuff, cosmetic and a variety of other compositions.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 3, 1998
    Assignee: Rhone-Poulenc Chimie
    Inventors: Magali Knipper, Michele Raffart, Alain Senechal
  • Patent number: 5827714
    Abstract: A .beta.-galactoside-.alpha.-2,6-sialyltransferase derived from a microorganism belonging to the genus Photobacterium has ben disclosed, having the following physicochemical properties:(1) action and specificity: transferring sialic acid from cytidine monophosphate-sialic acid to the 6-position of a galactose residue in a sugar chain of a glycoconjugate or in a free sugar chain, or to the 6-position of a monosaccharide having a hydroxyl group on carbon at the 6-position and being capable of forming a glycoconjugate.(2) optimum pH: 5 to 6;(3) optimum temperature: 30.degree. C.; and(4) molecular weight: 64,000.+-.5,000 (determined by gel filtration).
    Type: Grant
    Filed: October 28, 1996
    Date of Patent: October 27, 1998
    Assignee: Japan Tobacco Inc.
    Inventors: Takeshi Yamamoto, Motoko Nakashizuka, Ichiro Terada, Hisashi Kodama
  • Patent number: 5827699
    Abstract: This invention provides a new strain Rhodococcus rhodochrous having a high nitrile hydratase activity and capable of hydrating aliphatic and aromatic nitriles to corresponding amides. An isolated culture of Rhodococcus rhodochrous VKM Ac-1515D is also disclosed for use in the production of nitrile hydratase. An enzymatic inducer is not required in the growth medium, however, the growth medium does include a salt, a carbon source, and a nitrogen source.
    Type: Grant
    Filed: August 15, 1995
    Date of Patent: October 27, 1998
    Assignee: Gosudarstvenny. Nauchno-Issledovatelsky Institut Genetiki I Selektsii Promshlennykh Mikroorganizmov
    Inventors: Alexandr Stepanovich Yanenko, Olga Borisovna Astaurova, Sergei Petrovich Voronin, Tatyana Vasilievna Gerasimova, Nikolai Borisovich Kirsanov, Vladimir Nikolaevich Paukov, Inga Nikolaevna Polyakova, Vladimir Georgievich Debabov
  • Patent number: 5824538
    Abstract: We describe a bacterial delivery system for the delivery of DNA and antigens into cells. We constructed an attenuated bacterial vector which enters mammalian cells and ruptures delivering functional plasmid DNA, such as a mammalian expression plasmid, and antigens into the cell cytoplasm. This Shigella vector was designed to deliver DNA to colonic surfaces, thus opening the possibility of oral and other mucosal DNA immunization and gene therapy strategies. The attenuated Shigella is also useful as a vaccine for reducing disease symptoms caused by Shigella.
    Type: Grant
    Filed: September 6, 1995
    Date of Patent: October 20, 1998
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Arthur A. Branstrom, Donata R. Sizemore, Jerald C. Sadoff
  • Patent number: 5824449
    Abstract: A process for producing D-malic acid selectively without producing L-malic acid, using inexpensive maleic acid as a starting material, may be carried out using a microorganism belonging to the genus Erwinia, Mycoplana, Sporosarcina, Vibrio, Geotrichum or Torulaspora. The microorganism may be separated from the culture, used as a culture, or a treated microorganism.
    Type: Grant
    Filed: April 18, 1997
    Date of Patent: October 20, 1998
    Assignee: Ajinomoto Co., Inc.
    Inventors: Norimasa Ohnishi, Chisa Niwa, Kenzo Yokozeki
  • Patent number: 5820902
    Abstract: A physiologically active agent for fish is provided which comprises metabolite of green sulfur bacteria as an effective component thereof. The physiologically active agent, which can be easily prepared by the mass culture of green sulfur bacteria, exhibits an excellent efficiency as a feed additive, can be preserved for a long time and hence is economical.
    Type: Grant
    Filed: September 16, 1996
    Date of Patent: October 13, 1998
    Assignee: Araya Corporation
    Inventor: Akihisa Matsuura
  • Patent number: 5817362
    Abstract: A novel bacteriocin produced by Lactococcus lactis NRRL-B-18535 is described. The bacteriocin is useful in foods and other materials and has a wide spectrum of activity against Gram-positive bacteria in a pH range between 2 and 8.
    Type: Grant
    Filed: September 30, 1997
    Date of Patent: October 6, 1998
    Assignees: Quest International Flavors, Food Ingredients Company, Divison of Indopco, Inc.
    Inventors: Peter A. Vandenbergh, Shirley A. Walker, Blair S. Kunka
  • Patent number: 5814455
    Abstract: A sensitive and specific antigen preparation for the detection of Helicobacter pylori in biological samples is disclosed. The preparation uses a range of antigens derived from size exclusion chromatography of detergent-solubilized H. pylori cells. Serological assays such as ELISA, latex agglutination, and rapid EIA assays utilizing the improved antigen preparation, and a kit for use in these serological assays are also disclosed.
    Type: Grant
    Filed: August 18, 1994
    Date of Patent: September 29, 1998
    Assignee: Quidel Corporation
    Inventors: Allan David Pronovost, Jan Waclaw Pawlak, Kristy S. Condon
  • Patent number: 5814475
    Abstract: The invention relates to the human herpesvirus type 6 protein p100 and parts thereof having its specific immunological properties. It further relates to antibodies directed to them and to the corresponding DNA sequences. They can be used in pharmaceutical or diagnostic compositions, optionally together with other HHV-6 proteins or the corresponding DNA sequences.
    Type: Grant
    Filed: June 27, 1994
    Date of Patent: September 29, 1998
    Assignee: Behring Diagnostics GmbH
    Inventors: Frank Neipel, Bernhard Fleckenstein
  • Patent number: 5811293
    Abstract: An (R)-2-amino-1-phenylethanol derivative shown by the general formula (IIa) ##STR1## wherein R.sup.1 and R.sup.5 represent a hydrogen atom, etc.; R.sup.2, R.sup.3 and R.sup.4 independently represent a halogen atom, etc., or a salt thereof, can readily be produced (1) by permitting a microorganism belonging to the genus Rhodosporidium, the genus Comamonas or the like to act on a mixture of corresponding (R)-form and (S)-form to asymmetrically utilize, or (2) by permitting a microorganism belonging to the genus Lodderomyces, the genus Pilimelia or the like to act on a corresponding aminoketone derivative to asymmetrically reduce. An (R,R)-1-phenyl-2-?(2-phenyl-1-alkylethyl) amino!ethanol derivative having a high optical purity can easily be obtained from the compound of the formula (IIa) or a salt thereof. Said derivative is useful as an intermediate for producing an anti-obesity agent and so on.
    Type: Grant
    Filed: October 28, 1996
    Date of Patent: September 22, 1998
    Assignee: Daicel Chemical Industries, Ltd.
    Inventors: Kazuaki Furukawa, Takayuki Abe, Hidekazu Akamatsu, Akinobu Matsuyama, Michio Ito, Noritsugu Yamasaki, Katsuya Miki, Kiyoshi Ikura, Takeshi Ishiguro
  • Patent number: 5807736
    Abstract: A bacterial strain J1 (FERM BP-5102) which can effectively degrade aromatic compounds and/or chlorinated organic compounds such as trichloroethylene (TCE) is disclosed. Also the degradation occurs at a lower temperature such as 15.degree.. Further, a method for purifying waste water, soil or a gas polluted with the above chemical compounds utilizing the bacterium is disclosed.
    Type: Grant
    Filed: May 30, 1995
    Date of Patent: September 15, 1998
    Assignee: Canon Kabushiki Kaisha
    Inventors: Shinya Kozaki, Kinya Kato, Tetsuya Yano, Takeshi Imamura
  • Patent number: 5807730
    Abstract: The present invention provides the amino acid sequence and base sequence of a Pseudonocardia thermophila-derived nitrile hydratase, provides further a method for changing its amino acid sequence and base sequence without substantially changing the functions of said nitrile hydratase, and nitrile hydratases having a base sequence and an amino acid sequence as changed on the basis of said method, and provides furthermore a recombinant plasmid having the gene of said nitrile hydratase, a transformant containing said recombinant plasmid, a method of using said transformant for producing said enzyme, and a method of using said transformant for producing the corresponding amide compound from a nitrile compound.
    Type: Grant
    Filed: February 14, 1997
    Date of Patent: September 15, 1998
    Assignee: Mitsui Chemicals, Inc.
    Inventors: Kiyoshi Ito, Toshifumi Yamaki, Teruo Arii, Miyuki Tsuruoka, Takeshi Nakamura
  • Patent number: 5804425
    Abstract: Genes encoding Class II EPSPS enzymes are disclosed. The genes are useful in producing transformed bacteria and plants which are tolerant to glyphosate herbicide. Class II EPSPS genes share little homology with known, Class I EPSPS genes, and do not hybridize to probes from Class I EPSPS's. The Class II EPSPS enzymes are characterized by being more kinetically efficient than Class I EPSPS's in the presence of glyphosate. Plants transformed with Class II EPSPS genes are also disclosed as well as a method for selectively controlling weeds in a planted transgenic crop field.
    Type: Grant
    Filed: April 7, 1997
    Date of Patent: September 8, 1998
    Assignee: Monsanto Company
    Inventors: Gerard Francis Barry, Ganesh Murthy Kishore, Stephen Rogers Padgette, William Carlton Stallings
  • Patent number: 5798253
    Abstract: An accelerated micro-organism culture method is for decomposing harmful substances. For this purpose, the cultivation, mutagenic treatment and stabilization of the micro-organisms are carried out simultaneously in a mutation fermenter containing a nutrient-rich basic medium (basic medium 1); selection is carried out in a selection fermenter containing a basic medium which is low in nutrients and is enriched with the harmful substance (basic medium 2); small amounts of biomass released from the nutrient-rich basic medium (basic medium 1) of the mutation fermenter are continuously removed from the mutation fermenter and transferred to the selection fermenter. Small amounts of biomass released from the basic medium which is low in nutrients (basic medium 2) of the selection fermenter are removed from the selection fermenter and transferred to the mutation fermenter. The entire process is carried out continuously in alternating selection and mutation phases, in the manner of a repeated cycle.
    Type: Grant
    Filed: October 29, 1996
    Date of Patent: August 25, 1998
    Assignee: Bitop Gesellschaft fur Biotechnische Optimierung mbH
    Inventors: Peter Bartholmes, Michael Kaufmann, Thomas Schwarz
  • Patent number: 5786460
    Abstract: Novel antifungal antibiotics Cepacidine A (A.sub.1 and A.sub.2 ),a novel microorganism Pseudomonas cepacia AF 2001 producing the same, and a process for producing the said antibiotics are disclosed.
    Type: Grant
    Filed: June 18, 1996
    Date of Patent: July 28, 1998
    Assignee: Cheil Foods & Chemicals, Inc.
    Inventors: Sung Ho Kim, Bong Chul Hyun, Jung Woo Suh, Chang One Kim, Yoong Ho Lim, Chul Hoon Lee
  • Patent number: 5786167
    Abstract: The invention comprises a culture medium and method for distinguishing bacteria of Salmonella species from other gram-negative bacteria, especially those belonging to the family Enterobacteriaceae. It is based on the ability of salmonellae to utilize melibiose, mannitol, and sorbitol and convert them into acids, together with a chromogenic substrate used for identifying .beta.-galactosidase. Other bacteria of the family Enterobacteriaceae, most of which are .beta.-galactosidase-positive, appear as brown, blue, or green colonies, depending on the chromogenic substrate used. Apart from Salmonella species, other .beta.-galactosidase-negative bacteria, such as Proteus species, appear as colorless colonies. Salmonellae can be identified directly on the culture medium after incubation, by their characteristic bright red color.
    Type: Grant
    Filed: November 22, 1996
    Date of Patent: July 28, 1998
    Assignee: Orion-Yhtymae Oy
    Inventors: Helena Tuompo, Leena Scheinin, Marita Jussila, Irmeli Laine
  • Patent number: 5786162
    Abstract: The invention relates to a fused gene containing: the promoter sequence of (a) gene(s) encoding the resistance to one or several metal(s) or encoding the catabolism of one or several xenobiotic compound(s), said promoter being inducible in the presence of said metal(s) or xenobiotic compound(s), or both, and downstream the promoter, a gene producing a detectable signal such as light emitting gene, said gene being under the control of said promoter, said gene producing a detectable signal being located at a position such that the induction of the promoter causes the transcription of the gene producing a detectable signal and such that there is no terminator between the promoter and the gene producing a detectable signal.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: July 28, 1998
    Assignee: Vito
    Inventors: Philippe Corbisier, Maximilien Mergeay, Ludovicus Diels
  • Patent number: 5783410
    Abstract: The present invention discloses a bacteria-coding identification method,bacteria biochemical properties identifying papers which detect the biological properties using this method, and apparatus or means useful for identifying the genus and species of bacteria using the coding identification method and biochemical properties-identifying papers.
    Type: Grant
    Filed: May 28, 1996
    Date of Patent: July 21, 1998
    Assignee: Lin He
    Inventors: Lin He, Qiuming Liu, Baoduo Liang, Jinliang Wang
  • Patent number: 5776765
    Abstract: A compound of formula (II), either as a single enantiomer or in an enantiomerically enriched form ##STR1## wherein: ##STR2## and ##STR3## (wherein N in the benzimidazole moiety of Het.sub.2 means that one of the carbon atoms substituted by any one of R.sub.6 to R.sub.9 optionally may be exchanged for an unsubstituted nitrogen atom; R.sub.1, R.sub.2 and R.sub.3 are the same or different and selected from hydrogen, alkyl, alkoxy optionally substituted by fluorine, alkylthio, alkoxyalkoxy, dialkylamino, piperidino, morpholino, halogen, phenylalkyl, phenylakoxy; R.sub.4 and R.sub.4, are the same or different and selected from hydrogen, alkyl, aralkyl; R.sub.5 is hydrogen, halogen, trifluoromethyl, alkyl, alkoxy; R.sub.6 -R.sub.9 are the same or different and selected from hydrogen, alkyl, alkoxy, halogen, haloalkoxy, alkylcarbonyl, alkoxycarbonyl, oxazolyl, trifluoroalkyl or adjacent groups R.sub.6 -R.sub.
    Type: Grant
    Filed: December 18, 1995
    Date of Patent: July 7, 1998
    Assignee: Astra Aktiebolag
    Inventors: Daniel Graham, Robert Holt, Per Lindberg, Stephen Taylor
  • Patent number: 5776742
    Abstract: An aldehyde dehydrogenase having the physico-chemical properties: molecular weight: 91,000.+-.5,000; substrate specificity:active on aldehyde compounds; inhibition: by Cu.sup.2+, Zn.sup.2+, Ni.sup.2 + and ethylenediamine tetraacetic acid; optimum pH: 6.0-8.5; optimum temperature: 20.degree.-40.degree. C.; and stimulator: Ca.sup.2+ and pyrroloquinoline quinone, is derived from a microorganism belonging to the genus Gluconobacter. Said aldehyde dehydrogenase can be produced by cultivating a microorganism of the genus Gluconobacter which is capable of producing an aldehyde dehydrogenase having the above properties, in an aqueous nutrient medium under aerobic conditions, disrupting the cells of the microorganism and isolating and purifying the aldehyde dehydrogenase from the cell-free extract of the disrupted cells of the microorganism.
    Type: Grant
    Filed: February 6, 1997
    Date of Patent: July 7, 1998
    Assignee: Roche Vitamins Inc.
    Inventors: Tatsuo Hoshino, Teruhide Sugisawa